Lightbridge
Corporation:
|
Ogilvy
Public Relations:
|
Gerry
Pascale
|
Greg
Jawski
|
(571)
730-1213
|
212-880-5353
|
ir@Ltbridge.com
|
greg.jawski@ogilvypr.com
|
Three
Months Ended
|
Three
Months Ended
|
|||||||
31-March-10
|
31-March
09
|
|||||||
GAAP
Net Income (Loss)
|
$
|
(1,684)
|
$
|
(1,522)
|
||||
Adjustments:
|
||||||||
Expense
- non-cash employee compensation
|
860
|
1,273
|
||||||
Expense
- depreciation
|
7
|
6
|
||||||
Adjusted
Net Income (Loss)
|
$
|
(817)
|
$
|
(243)
|
March
31,
|
December
31,
|
|||||||
2010
|
2009
|
|||||||
(Unaudited)
|
||||||||
ASSETS
|
||||||||
Current
Assets
|
||||||||
Cash
and cash equivalents
|
$ | 2,000,134 | $ | 3,028,791 | ||||
Restricted
cash
|
652,174 | 652,174 | ||||||
Accounts
receivable - project revenue and reimbursable project
costs
|
2,647,233 | 2,421,088 | ||||||
Prepaid
expenses & other current assets
|
675,523 | 574,095 | ||||||
Total
Current Assets
|
5,975,064 | 6,676,148 | ||||||
Property
Plant and Equipment -net
|
90,608 | 97,559 | ||||||
Other
Assets
|
||||||||
Patent
costs - net
|
241,845 | 241,845 | ||||||
Security
deposits
|
120,487 | 120,486 | ||||||
Total
Other Assets
|
362,332 | 362,331 | ||||||
Total
Assets
|
$ | 6,428,004 | $ | 7,136,038 | ||||
LIABILITIES
AND STOCKHOLDERS EQUITY
|
||||||||
Current
Liabilities
|
||||||||
Accounts
payable and accrued liabilities
|
$ | 1,575,718 | $ | 2,162,221 | ||||
Total
Liabilities
|
1,575,718 | 2,162,221 | ||||||
Commitments
and contingencies
|
||||||||
Stockholders'
Equity
|
||||||||
Preferred
stock, $0.001 par value, 50,000,000 authorized shares, no shares issued
and outstanding
|
- | - | ||||||
Common
stock, $0.001par value, 500,000,000 authorized, 10,168,412 shares issued and
outstanding at March 31, 2010 and December 31,
2009
|
10,168 | 10,168 | ||||||
Additional
paid in capital - stock and stock equivalents
|
54,836,265 | 54,108,685 | ||||||
Deficit
|
(50,407,044 | ) | (48,723,286 | ) | ||||
Common
stock reserved for issuance, 135,318 and 5,721 shares at March 31, 2010
and 2009, respectively
|
1,134,264 | 34,750 | ||||||
Deferred
stock compensation
|
(721,367 | ) | (456,500 | ) | ||||
Total
Stockholders' Equity
|
4,852,286 | 4,973,817 | ||||||
Total
Liabilities and Stockholders' Equity
|
$ | 6,428,004 | $ | 7,136,038 |
Three
Months Ended
|
||||||||
March,
31
|
||||||||
2010
|
2009
|
|||||||
Revenue:
|
||||||||
Consulting
Revenue
|
$ | 2,399,132 | $ | 2,944,053 | ||||
Cost
of Consulting Services Provided
|
1,505,490 | 1,748,518 | ||||||
Gross
Margin
|
893,642 | 1,195,535 | ||||||
Operating
Expenses
|
||||||||
General
and administrative
|
2,372,263 | 2,262,681 | ||||||
Research
and development expenses
|
204,743 | 453,805 | ||||||
Total
Operating Expenses
|
2,577,006 | 2,716,486 | ||||||
Operating
loss
|
(1,683,364 | ) | (1,520,951 | ) | ||||
Other
Income and (Expenses)
|
||||||||
Interest
income
|
152 | 3,028 | ||||||
Other
|
(546 | ) | (4,538 | ) | ||||
Realized
gain on marketable securities
|
0 | |||||||
Total
Other Income and Expenses
|
(394 | ) | (1,510 | ) | ||||
Net loss
before income taxes
|
(1,683,758 | ) | (1,522,461 | ) | ||||
Income
taxes
|
0 | 0 | ||||||
Net loss
|
$ | (1,683,758 | ) | $ | (1,522,461 | ) | ||
Net
Loss Per Common Share, Basic and diluted
|
$ | (0.17 | ) | $ | (0.15 | ) | ||
Weighted
Average Number of shares outstanding for the period used to compute per
share data - (prior reporting period restated to reflect 1 for 30 reverse
stock split)
|
10,168,412 | 10,055,580 |
Three
Months Ended
|
||||||||
March
31,
|
||||||||
2010
|
2009
|
|||||||
Operating
Activities:
|
||||||||
Net
Loss
|
$ | (1,683,758 | ) | $ | (1,522,461 | ) | ||
Adjustments
to reconcile net loss from operations to net cash used in operating
activities:
|
||||||||
Stock
based compensation
|
859,576 | 1,272,971 | ||||||
Depreciation
and amortization
|
6,951 | 6,004 | ||||||
Changes
in non-cash operating working capital items:
|
||||||||
Accounts
receivable - fees and reimburseable project costs
|
(226,145 | ) | 1,038,592 | |||||
Prepaid
expenses and other current assets
|
(101,428 | ) | (387,189 | ) | ||||
Accounts
payable, accrued liabilities and other current liabilities
|
116,147 | (1,596,398 | ) | |||||
Net
Cash Used In Operating Activities
|
(1,028,657 | ) | (1,188,481 | ) | ||||
Investing
Activities:
|
||||||||
Patent
costs
|
0 | (16,402 | ) | |||||
Net
Cash Used In Investing Activities
|
0 | (16,402 | ) | |||||
Financing
Activities:
|
||||||||
Net
Cash Provided by (Used In) Financing Activities
|
0 | 0 | ||||||
Net
Decrease In Cash and Cash Equivalents
|
(1,028,657 | ) | (1,204,883 | ) | ||||
Cash
and Cash Equivalents, Beginning of Period
|
3,028,791 | 5,580,244 | ||||||
Cash
and Cash Equivalents, End of Period
|
$ | 2,000,134 | $ | 4,375,361 | ||||
Supplemental
Disclosure of Cash Flow Information
|
||||||||
Cash
paid during the year:
|
||||||||
Interest
paid
|
$ | 0 | $ | 0 | ||||
Income
taxes paid
|
$ | 0 | $ | 266,000 | ||||
Non-Cash
Financing Activity
|
||||||||
Grant
of Common Stock for Payment of Accrued Liabilities
|
$ | 703,651 | $ | 0 |